Explorer les evidences

38 %Among 65 severe morbidity episodes, tuberculosis accounted for 25 episodes (38%).

Côte d'Ivoiretuberculosepublié 2007AIDS (London, England)europe_pmcdocument de 9 observations

6,7 %Among 344 HIV-infected pregnant women who conceived on antiretroviral therapy, the overall proportion of stillborn was 6.7%.

Côte d'IvoireVIH/sidaobservé 2003–2009publié 2011Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0b013e3181ff04e6

365 daysAntibody responses were observed until Day 365.

Côte d'Ivoiremaladie à virus Ebolapublié 2021PLoS medicineeurope_pmcdocument de 6 observationsDOI 10.1371/journal.pmed.1003813

25,1 %Among individuals with LLIN possession, malaria prevalence was 25.1%.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

0 %Plasmodium malariae accounted for 0.00% of 2246 identified Plasmodium species.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

100 %Among participants who slept under an LLIN the night before the survey, infection prevalence was 100.0%.

Côte d'IvoirepaludismeHAL · Unilimdocument de 122 observations

85,4 %Between 2003 and 2005, Plasmodium parasite prevalence ranged from 85.4% to 100% in six villages in northern Côte d’Ivoire.

Côte d'Ivoirepaludismeobservé 2003–2005HAL · Unilimdocument de 122 observations

35,3 %Thirty months after ART initiation, patients in the deferred group had a higher rate of virological failure (35.3% versus 29.9%).

Côte d'IvoireVIH/sidapublié 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument de 8 observations

50 copies/mm3Virologic failure was defined as viral load > 50 copies/mm³.

Côte d'IvoireVIH/sidapublié 2025PloS oneeurope_pmcdocument de 12 observations

2 409 patientsAmong 2409 sickle cell disease patients in the CADRE cohort from Ivory Coast, Cameroon, and Mali, 1751 had the SS-Sβ0 phenotype and 658 had the SC-Sβ+ phenotype.

Cameroun · Côte d'Ivoire · Malidrépanocytosepublié 2015BloodOpenAlexdocument de 16 observations

5,2 yearsThe interquartile range of follow-up duration was 5.2–6.3 years.

Côte d'IvoireVIH/sidapublié 2022HIV medicineeurope_pmcdocument de 6 observations

1,31 hazard_ratioPatients aged 50–59 years had an increased risk of death in the first 36 months on ART with an adjusted hazard ratio of 1.31.

Côte d'IvoireVIH/sidapublié 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument de 7 observations

93,5 %The symptomatology of cryptococcal meningitis was subacute in 93.5% of cases.

Côte d'Ivoireméningite cryptococciqueobservé 2008 to 2011publié 2017Journal de mycologie medicaleeurope_pmcdocument de 11 observations

6,5 %Two (6.5%) HIV-2 patients switched to a PI-based regimen.

Côte d'IvoireVIH/sidapublié 2020PloS oneeurope_pmcdocument de 13 observationsDOI 10.1371/journal.pone.0236642

2,42 %In Bouaké, symptomatic cases prevalence recorded in August 2016 was 2.42%.

Côte d'Ivoirepaludismeobservé August 2016HAL · Unilimdocument de 122 observations

0,9 sensitivityqHBsAg levels ≤ 100 IU/mL at month 12 had sensitivity of 0.90 and specificity of 1.00 for predicting HBsAg seroclearance.

Côte d'Ivoirehépatite Bobservé month 12publié 2016Journal of gastroenterology and hepatologyeurope_pmcdocument de 11 observationsDOI 10.1111/jgh.13156

28,8 %Twelve S-gene MUPIQHs were identified among 21 of 73 HIV-HBV co-infected patients from Côte d'Ivoire, representing 28.8%.

Côte d'Ivoirehépatite Bpublié 2019Liver international : official journal of the International Association for the Study of teurope_pmcdocument de 4 observationsDOI 10.1111/liv.13975

3,7 yearsMean time on failed first-line antiretroviral therapy was 3.7 years for the standard of care.

Côte d'IvoireVIH/sidapublié 2016Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 5 observations

2,09 hazard_ratioIn multivariate Cox regression analysis, HIV-1 DNA levels ≥3 log10 copies/million PBMC were strongly associated with mortality (adjusted hazard ratio = 2.09, 95% CI 1.24–3.52, p = 0.005).

Côte d'IvoireVIH/sidapublié 2020EBioMedicineeurope_pmcdocument de 7 observations

10,8 %Of 457 participants included in this study, 39 (10.8%) had cavitation on chest X-ray.

Côte d'Ivoiretuberculosepublié 2025BMC infectious diseaseseurope_pmcdocument de 9 observations

86,9 %Prevalence of P. falciparum infection in the LLIN group was 86.9% (2886/3321) post-intervention.

Côte d'IvoirepaludismeHAL · Unilimdocument de 54 observations

0,61 hazard_ratio6 months of isoniazid preventive therapy reduced all-cause mortality with a hazard ratio of 0.61 (95% CI 0.39 to 0.94) after adjustment for ART strategy, baseline CD4 cell count, and other key characteristics in HIV-infected adults in Côte d'Ivoire.

Côte d'IvoireVIH/sidapublié 2017The Lancet. Global healtheurope_pmcdocument de 6 observations

41 %For children living with HIV, bacterial infections were the leading cause of hospital admission, accounting for 41% of admissions.

Côte d'Ivoirebacterial infectionspublié 2015The lancet. HIVeurope_pmcdocument de 8 observations

10 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 10% had occult HBV infection.

Côte d'Ivoirehépatite B · VIH/sidapublié 2010Antiviral therapyeurope_pmcdocument de 7 observations

5 %Anopheles funestus group constituted 5% of malaria vectors in Korhogo health district, northern Côte d’Ivoire.

Côte d'Ivoirepaludismeobservé 1990s–2000sHAL · Unilimdocument de 122 observations